$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 2 3 4 5 6 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 08 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 5,204 | 0 | 9,899 | 4.7 K to 9.9 K (+110.84 %) |
Oct 08 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Grant | A | 0.00 | 19,516 | 0 | 32,654 | 13.1 K to 32.7 K (+148.55 %) |
Oct 08 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Grant | A | 0.00 | 19,516 | 0 | 32,654 | 13.1 K to 32.7 K (+148.55 %) |
Oct 08 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Grant | A | 0.00 | 41,654 | 0 | 54,668 | 13 K to 54.7 K (+320.07 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Option Exercise | M | 41.64 | 5,718 | 238,098 | 11,435 | |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 128.66 | 467 | 60,084 | 13,014 | 13.5 K to 13 K (-3.46 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 127.80 | 648 | 82,814 | 13,481 | 14.1 K to 13.5 K (-4.59 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 126.72 | 1,670 | 211,622 | 14,129 | 15.8 K to 14.1 K (-10.57 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 125.71 | 1,309 | 164,554 | 15,799 | 17.1 K to 15.8 K (-7.65 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 124.47 | 3,070 | 382,123 | 17,108 | 20.2 K to 17.1 K (-15.21 %) |
Oct 03 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Buy | M | 41.64 | 5,718 | 238,098 | 20,178 | 14.5 K to 20.2 K (+39.54 %) |
Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 93.52 | 1,308 | 122,324 | 3,925 | |
Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 127.44 | 1,531 | 195,111 | 4,695 | 6.2 K to 4.7 K (-24.59 %) |
Sep 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 93.52 | 1,308 | 122,324 | 6,226 | 4.9 K to 6.2 K (+26.60 %) |
Sep 09 2019 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Sell | S | 129.94 | 101 | 13,124 | 2,770 | 2.9 K to 2.8 K (-3.52 %) |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Option Exercise | M | 93.52 | 832 | 77,809 | 2,498 | |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Option Exercise | M | 93.52 | 832 | 77,809 | 2,498 | |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Sell | S | 133.73 | 657 | 87,861 | 2,316 | 3 K to 2.3 K (-22.10 %) |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Sell | S | 133.73 | 657 | 87,861 | 2,316 | 3 K to 2.3 K (-22.10 %) |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Buy | M | 93.52 | 832 | 77,809 | 2,973 | 2.1 K to 3 K (+38.86 %) |
Sep 03 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Buy | M | 93.52 | 832 | 77,809 | 2,973 | 2.1 K to 3 K (+38.86 %) |
Aug 21 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 137.43 | 50,869 | 6,990,927 | 304,572 | 355.4 K to 304.6 K (-14.31 %) |
Aug 15 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Grant | A | 0.00 | 114,298 | 0 | 355,441 | 241.1 K to 355.4 K (+47.40 %) |
Aug 12 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 134.15 | 1,696 | 227,518 | 48,384 | 50.1 K to 48.4 K (-3.39 %) |
Aug 12 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | M | 93.52 | 475 | 44,422 | 1,428 | |
Aug 12 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 133.23 | 475 | 63,284 | 2,789 | 3.3 K to 2.8 K (-14.55 %) |
Aug 12 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Buy | M | 93.52 | 475 | 44,422 | 3,264 | 2.8 K to 3.3 K (+17.03 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Grant | A | 0.00 | 1,460 | 0 | 4,457 | 3 K to 4.5 K (+48.72 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | Pomeroy Claire | Director | Grant | A | 0.00 | 1,460 | 0 | 1,956 | 496 to 2 K (+294.35 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.00 | 1,460 | 0 | 30,067 | 28.6 K to 30.1 K (+5.10 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,460 | 0 | 23,617 | 22.2 K to 23.6 K (+6.59 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,460 | 0 | 50,080 | 48.6 K to 50.1 K (+3.00 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,460 | 0 | 20,340 | 18.9 K to 20.3 K (+7.73 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | BURZIK CATHERINE M | Director | Grant | A | 0.00 | 1,460 | 0 | 11,755 | 10.3 K to 11.8 K (+14.18 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 1,460 | 0 | 6,065 | 4.6 K to 6.1 K (+31.70 %) |
Jul 02 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 121.79 | 5,008 | 609,924 | 241,143 | 246.2 K to 241.1 K (-2.03 %) |
Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 41.64 | 2,890 | 120,340 | 5,779 | |
Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 259 | 29,135 | 4,918 | 5.2 K to 4.9 K (-5.00 %) |
Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 497 | 55,908 | 5,177 | 5.7 K to 5.2 K (-8.76 %) |
Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.49 | 2,890 | 325,096 | 5,674 | 8.6 K to 5.7 K (-33.75 %) |
Jun 18 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 41.64 | 2,890 | 120,340 | 8,564 | 5.7 K to 8.6 K (+50.93 %) |
Jun 17 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 110.58 | 94 | 10,395 | 2,789 | 2.9 K to 2.8 K (-3.26 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 109.37 | 39 | 4,265 | 2,883 | 2.9 K to 2.9 K (-1.33 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Sell | S | 109.37 | 69 | 7,547 | 2,141 | 2.2 K to 2.1 K (-3.12 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 109.37 | 108 | 11,812 | 5,674 | 5.8 K to 5.7 K (-1.87 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Sell | S | 109.37 | 231 | 25,264 | 13,138 | 13.4 K to 13.1 K (-1.73 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 109.37 | 190 | 20,780 | 14,460 | 14.7 K to 14.5 K (-1.30 %) |
Jun 13 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 109.37 | 1,248 | 136,494 | 246,151 | 247.4 K to 246.2 K (-0.50 %) |
Jun 12 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 104.38 | 192 | 20,041 | 2,922 | 3.1 K to 2.9 K (-6.17 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | M | 41.64 | 1,107 | 46,095 | 2,213 | |
Jun 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 103.38 | 78 | 8,064 | 3,114 | 3.2 K to 3.1 K (-2.44 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 103.25 | 1,107 | 114,298 | 3,192 | 4.3 K to 3.2 K (-25.75 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Buy | M | 41.64 | 1,107 | 46,095 | 4,299 | 3.2 K to 4.3 K (+34.68 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 103.38 | 208 | 21,503 | 5,782 | 6 K to 5.8 K (-3.47 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Option Exercise | M | 38.43 | 4,872 | 187,231 | 14,618 | |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Option Exercise | M | 41.64 | 6,148 | 256,003 | 18,444 | |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Sell | S | 103.38 | 442 | 45,694 | 13,369 | 13.8 K to 13.4 K (-3.20 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Sell | S | 103.50 | 6,745 | 698,108 | 13,811 | 20.6 K to 13.8 K (-32.81 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Buy | M | 38.43 | 4,872 | 187,231 | 20,556 | 15.7 K to 20.6 K (+31.06 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Sell | S | 103.25 | 6,148 | 634,781 | 15,684 | 21.8 K to 15.7 K (-28.16 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Buy | M | 41.64 | 6,148 | 256,003 | 21,832 | 15.7 K to 21.8 K (+39.20 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 103.38 | 411 | 42,489 | 14,650 | 15.1 K to 14.7 K (-2.73 %) |
Jun 10 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 103.38 | 2,834 | 292,979 | 247,399 | 250.2 K to 247.4 K (-1.13 %) |
May 24 2019 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 1,449 | 0 | 22,157 | 23.6 K to 22.2 K (-6.14 %) |
May 24 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 99.39 | 24,412 | 2,426,309 | 250,233 | 274.6 K to 250.2 K (-8.89 %) |
May 24 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Grant | A | 0.00 | 53,654 | 0 | 274,645 | 221 K to 274.6 K (+24.28 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | A | 98.03 | 2,003 | 196,344 | 2,003 | |
May 16 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Grant | A | 0.00 | 573 | 0 | 3,192 | 2.6 K to 3.2 K (+21.88 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Option Exercise | A | 98.03 | 5,342 | 523,650 | 5,342 | |
May 16 2019 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Grant | A | 0.00 | 1,530 | 0 | 2,871 | 1.3 K to 2.9 K (+114.09 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | A | 98.03 | 2,003 | 196,344 | 2,003 | |
May 16 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Grant | A | 0.00 | 573 | 0 | 3,192 | 2.6 K to 3.2 K (+21.88 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Option Exercise | A | 98.03 | 5,342 | 523,650 | 5,342 | |
May 16 2019 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Grant | A | 0.00 | 1,530 | 0 | 2,871 | 1.3 K to 2.9 K (+114.09 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Option Exercise | A | 98.03 | 4,451 | 436,309 | 4,451 | |
May 16 2019 | HAE | HAEMONETICS CORP | Bolorforosh Said | EVP, Chief Technolo ... | Grant | A | 0.00 | 1,275 | 0 | 2,210 | 935 to 2.2 K (+136.36 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | A | 98.03 | 5,342 | 523,650 | 5,342 | |
May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 2,599 | |
May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Grant | A | 0.00 | 1,530 | 0 | 5,990 | 4.5 K to 6 K (+34.30 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 100.00 | 1,508 | 150,800 | 4,237 | 5.7 K to 4.2 K (-26.25 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 5,745 | 4.4 K to 5.7 K (+29.22 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Option Exercise | A | 98.03 | 9,794 | 960,057 | 9,794 | |
May 16 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Grant | A | 0.00 | 2,805 | 0 | 15,684 | 12.9 K to 15.7 K (+21.78 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Option Exercise | A | 98.03 | 48,971 | 4,800,382 | 48,971 | |
May 16 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Grant | A | 0.00 | 14,027 | 0 | 220,991 | 207 K to 221 K (+6.78 %) |
May 16 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Option Exercise | A | 98.03 | 10,684 | 1,047,299 | 10,684 | |
May 16 2019 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Grant | A | 0.00 | 3,060 | 0 | 15,061 | 12 K to 15.1 K (+25.50 %) |
May 15 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 94.51 | 57,587 | 5,442,547 | 206,964 | 264.6 K to 207 K (-21.77 %) |
May 01 2019 | HAE | HAEMONETICS CORP | Pomeroy Claire | Director | Grant | A | 0.00 | 496 | 0 | 496 | 0 to 496 |
Apr 25 2019 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Grant | A | 0.00 | 131,050 | 0 | 264,317 | 133.3 K to 264.3 K (+98.34 %) |
Apr 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | M | 34.42 | 2,607 | 89,733 | 2,607 | |
Apr 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 88.99 | 389 | 34,617 | 2,619 | 3 K to 2.6 K (-12.93 %) |
Apr 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 88.31 | 210 | 18,545 | 3,008 | 3.2 K to 3 K (-6.53 %) |
Apr 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 88.93 | 2,607 | 231,841 | 3,218 | 5.8 K to 3.2 K (-44.76 %) |
Apr 10 2019 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Buy | M | 34.42 | 2,607 | 89,733 | 5,825 | 3.2 K to 5.8 K (+81.01 %) |
Mar 11 2019 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 83.57 | 116 | 9,694 | 4,446 | 4.6 K to 4.4 K (-2.54 %) |
Mar 11 2019 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP and General Cou ... | Sell | S | 83.57 | 391 | 32,676 | 12,879 | 13.3 K to 12.9 K (-2.95 %) |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 86.52 | 8,196 | 709,118 | 53,062 | 61.3 K to 53.1 K (-13.38 %) |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 36.37 | 8,196 | 298,089 | 61,258 | 53.1 K to 61.3 K (+15.45 %) |
Dec 18 2018 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Dec 18 2018 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Sell | S | 102.86 | 8,196 | 843,041 | 28,607 | 36.8 K to 28.6 K (-22.27 %) |
Dec 18 2018 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Buy | M | 36.37 | 8,196 | 298,089 | 36,803 | 28.6 K to 36.8 K (+28.65 %) |
Dec 18 2018 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 103.02 | 4,329 | 445,974 | 53,062 | 57.4 K to 53.1 K (-7.54 %) |
Dec 14 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 104.22 | 1,027 | 107,034 | 4,562 | 5.6 K to 4.6 K (-18.38 %) |
Dec 12 2018 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Option Exercise | M | 34.21 | 1,457 | 49,844 | 2,913 | |
Dec 12 2018 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 102.91 | 1,693 | 174,227 | 3,218 | 4.9 K to 3.2 K (-34.47 %) |
Dec 12 2018 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Buy | M | 34.21 | 1,457 | 49,844 | 4,911 | 3.5 K to 4.9 K (+42.18 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Option Exercise | M | 34.21 | 11,232 | 384,247 | 22,463 | |
Nov 09 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 114.33 | 13,056 | 1,492,692 | 12,001 | 25.1 K to 12 K (-52.11 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Buy | M | 34.21 | 11,232 | 384,247 | 25,057 | 13.8 K to 25.1 K (+81.24 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 114.50 | 12,322 | 1,410,869 | 15,335 | 27.7 K to 15.3 K (-44.55 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 114.00 | 10,707 | 1,220,598 | 24,748 | 35.5 K to 24.7 K (-30.20 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 36.37 | 8,196 | 298,089 | 35,455 | 27.3 K to 35.5 K (+30.07 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 200 | 0 | 27,259 | 27.5 K to 27.3 K (-0.73 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 1,000 | 0 | 27,459 | 28.5 K to 27.5 K (-3.51 %) |
Oct 30 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 101.69 | 779 | 79,217 | 13,825 | 14.6 K to 13.8 K (-5.33 %) |
Oct 30 2018 | HAE | HAEMONETICS CORP | Goldstein Dan | VP, Corporate Contr ... | Sell | S | 101.69 | 102 | 10,372 | 3,454 | 3.6 K to 3.5 K (-2.87 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 35.50 | 10,353 | 367,532 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 45.45 | 6,573 | 298,743 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 114.16 | 631 | 72,035 | 27,657 | 28.3 K to 27.7 K (-2.23 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 113.16 | 11,812 | 1,336,646 | 28,288 | 40.1 K to 28.3 K (-29.46 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 111.33 | 13,183 | 1,467,663 | 40,100 | 53.3 K to 40.1 K (-24.74 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 110.11 | 3,696 | 406,967 | 53,283 | 57 K to 53.3 K (-6.49 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 108.92 | 1,502 | 163,598 | 56,979 | 58.5 K to 57 K (-2.57 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 35.50 | 10,353 | 367,532 | 58,481 | 48.1 K to 58.5 K (+21.51 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 45.45 | 6,573 | 298,743 | 48,128 | 41.6 K to 48.1 K (+15.82 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 36.37 | 8,196 | 298,089 | 41,555 | 33.4 K to 41.6 K (+24.57 %) |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 41.64 | 2,889 | 120,298 | 8,669 | |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Option Exercise | M | 38.43 | 1,299 | 49,921 | 3,898 | |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 702 | 78,757 | 5,551 | 6.3 K to 5.6 K (-11.23 %) |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 2,889 | 324,117 | 6,253 | 9.1 K to 6.3 K (-31.60 %) |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 41.64 | 2,889 | 120,298 | 9,142 | 6.3 K to 9.1 K (+46.20 %) |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Sell | S | 112.19 | 1,299 | 145,735 | 6,253 | 7.6 K to 6.3 K (-17.20 %) |
Sep 12 2018 | HAE | HAEMONETICS CORP | Scanlan Jacqueline | SVP, Global Human R ... | Buy | M | 38.43 | 1,299 | 49,921 | 7,552 | 6.3 K to 7.6 K (+20.77 %) |
Sep 06 2018 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Option Exercise | A | 111.84 | 4,714 | 527,214 | 4,714 | |
Sep 06 2018 | HAE | HAEMONETICS CORP | Llorens Josep | SVP, Global Manufac ... | Grant | A | 0.00 | 1,341 | 0 | 1,341 | 0 to 1.3 K |
Jul 30 2018 | HAE | HAEMONETICS CORP | ABERNATHY ROBERT E | Director | Grant | A | 0.00 | 1,696 | 0 | 4,605 | 2.9 K to 4.6 K (+58.30 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Grant | A | 0.00 | 1,696 | 0 | 2,997 | 1.3 K to 3 K (+130.36 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,696 | 0 | 28,459 | 26.8 K to 28.5 K (+6.34 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 1,696 | 0 | 33,359 | 31.7 K to 33.4 K (+5.36 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,696 | 0 | 57,391 | 55.7 K to 57.4 K (+3.05 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | BURZIK CATHERINE M | Director | Grant | A | 0.00 | 1,696 | 0 | 10,295 | 8.6 K to 10.3 K (+19.72 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 1,696 | 0 | 18,880 | 17.2 K to 18.9 K (+9.87 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.00 | 1,696 | 0 | 28,607 | 26.9 K to 28.6 K (+6.30 %) |
Jul 05 2018 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Sell | S | 89.31 | 5,139 | 458,964 | 133,126 | 138.3 K to 133.1 K (-3.72 %) |
Jun 27 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Option Exercise | M | 41.64 | 5,717 | 238,056 | 17,153 | |
Jun 27 2018 | HAE | HAEMONETICS CORP | Burke William P. Mr. | EVP, Chief Financia ... | Sell | S | 92.17 | 970 | 89,405 | 14,604 | 15.6 K to 14.6 K (-6.23 %) |